| Product Name |
MF |
CAS |
Details |
| 5-Chloro-N-(2-fluorobenzyl)-2-Methylaniline, 97% |
C14H13ClFN |
1036483-41-6 |
|
| 4-Fluoro-N-(3-fluoro-2-Methylphenyl)benzaMide, 97% |
C14H11F2NO |
1032226-70-2 |
|
| 3-(3,5-DibroMophenyl)propionic acid, 97% |
C9H8Br2O2 |
923977-15-5 |
|
| 3-(2,3,3-TriMethyl-3H-indol-5-yl)propionic acid, 96% |
C14H17NO2 |
1072069-91-0 |
|
| Methyl 1,3-diMethyl-2,4-dioxo-7-propyl-2,3,4,7-tetrahydro-1H-pyrrolo[2,3-d]pyriMidine-6-carboxylate, 96% |
C13H17N3O4 |
1086386-30-2 |
|
| 7-Benzyl-1,3-diMethyl-2,4-dioxo-2,3,4,7-tetrahydro-1H-pyrrolo[2,3-d]pyriMidine-6-carboxylic acid, 96% |
C16H15N3O4 |
1086386-28-8 |
|
| 1-(3-Methoxypropyl)-4-oxo-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyriMidine-2-carboxylic acid, 96% |
C15H15N3O4 |
1086386-77-7 |
|
| 2-Chloro-3-iodo-1,4-diMethoxybenzene |
C8H8ClIO2 |
1335243-55-4 |
|
| N-(3-Fluorobenzyl)-4-fluorobenzylaMine, 97% |
C14H13F2N |
1019602-14-2 |
|
| N-(2-Fluorobenzyl)-2-(trifluoroMethyl)aniline, 97% |
C14H11F4N |
1024247-14-0 |
|
| 2,4-Difluoro-N-(2-fluorobenzyl)aniline, 97% |
C13H10F3N |
1019514-24-9 |
|
| N-(4-Fluorobenzyl)-2-Methylaniline, 97% |
C14H14FN |
1020963-78-3 |
|
| 4-BroMo-2-chloro-N-(2-fluorobenzyl)aniline, 97% |
C13H10BrClFN |
1094533-17-1 |
|
| 4-BroMo-N-(3-fluorobenzyl)-3-Methylaniline, 97% |
C14H13BrFN |
1019563-46-2 |
|
| 2-Fluoro-N-(2-fluorobenzyl)-4-Methylaniline, 97% |
C14H13F2N |
1039823-53-4 |
|
| 3-[[(1R,2R)-2-(1-Piperidinyl)cyclohexyl]amino]-4-[[4-(trifluoromethyl)phenyl]amino]-3-cyclobutene-1,2-dione |
C22H26F3N3O2 |
1211565-08-0 |
|
| (2(S)-[1-(3,5-Dichlorophenylsulfonyl)-L-prolylaMino]-4-[N-Methyl-N-[2-[4-[3-(2-Methylphenyl)ureido]phenyl]acetyl]-L-leucylaMino]butyric acid ) |
C38H46Cl2N6O8S |
327613-57-0 |
|
| (R)-Benzyl-2-[4-(trifluoroMethyl)phenyl]-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazoliuM Tetrafluoroborate |
C19H17BF7N3 |
862095-77-0 |
|
| 1,3-DiMethyl 2-[4-(Methoxycarbonyl)-2-nitrophenyl]propanedioate |
C13H13NO8 |
1160293-27-5 |
|
| Cyclo(-Pro-Gly)3 |
C21H30N6O6 |
37783-51-0 |
|
| Benzyl 5-bromo-4-oxo-3,4-dihydropyridine-1(2H)-carboxylate |
C13H12BrNO3 |
865996-16-3 |
|
| N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine |
C13H19N5 |
1260614-73-0 |
|
| 3-Chloropropane-1-sulfonaMide |
C3H8ClNO2S |
35578-28-0 |
|
| 4-aMino-2-broMobenzaldehyde |
C7H6BrNO |
655248-57-0 |
|
| 2-(5-oxo-5H-chroMeno[2,3-b]pyridin-7-yl)propanoic acid |
C15H11NO4 |
52549-19-6 |
|
| 4,5-dihydro-a-(hydroxyMethyl)-a,3-diMethyl-5-oxo-1-phenyl-1H-Pyrazole-4-Methanesulfonic acid |
C13H16N2O5S |
1242471-40-4 |
|
| FMOC-1-AMINO-4,7,10-TRIOXA-13-TRIDECANAMINE SUCCINIMIC ACID |
C29H38N2O8 |
172089-14-4 |
|
| [3-(4-FLUOROPHENYL)PHENYL]METHYLAMINEHCL |
C13H13ClFN |
1195901-44-0 |
|
| 2,8-Diiodo-dibenzofuran |
C12H6I2O |
5943-11-3 |
|
| Tarafenacin (D-tartrate) |
C25H26F4N2O8 |
1159101-48-0 |
|
| 2,4,5-tribroMo-1-ethyl-1H-iMidazole |
C5H5Br3N2 |
31250-75-6 |
|
| POLY(ALLYLAMINE) |
C3H7N |
30551-89-4 |
|
| FLAVOKAVAIN A(P) |
C18H18O5 |
37951-13-6 |
|
| (S)-3-(2-aMino-3-MethylbutanaMido)propane-1-sulfonic acid |
C8H18N2O4S |
1034190-08-3 |
|
| Tivozanib |
C22H22Cl2N4O6 |
682745-41-1 |
|
| Tivozanib |
C22H22Cl2N4O6 |
682745-41-1 |
|
| 4-BroMobenzeneMethanesulfonaMide |
C7H8BrNO2S |
64732-38-3 |
|
| Ethyl 2-oxo-1,2,3,4-tetrahydroquinoline-6-carboxylate |
C12H13NO3 |
70639-79-1 |
|
| 2-Chloro-6-(trifluoroMethyl)pyrazine |
C5H2ClF3N2 |
61655-69-4 |
|
| ThioMorpholine-1-oxide HCl |
C4H10ClNOS |
76176-87-9 |
|
| 2,3-Dihydro-1H-pyrrolo[1,2-a]indole |
C11H11N |
1421-19-8 |
|
| 5-broMo-2,4-dichloro-3-nitropyridine |
C5HBrCl2N2O2 |
856850-68-5 |
|
| (S)-N-ethylalanine Methyl ester |
C8H17NO2 |
222550-60-9 |
|
| 6-broMo-5-(trifluoroMethyl)pyridin-3-aMine |
C6H4BrF3N2 |
1642844-33-4 |
|
| (R)-5-(hydroxyMethyl)oxazolidin-2-one |
C4H7NO3 |
97859-49-9 |
|
| 2-Bromo-13,13-dimethyl-6,11-di-2-naphthalenyl-13H-indeno[1,2-b]anthracene |
C43H29Br |
1196107-75-1 |
|
| 1,2-Dibromo-4,5-diethoxy-3-fluorobenzene |
C10H11Br2FO2 |
474554-34-2 |
|
| Methyl 6-aMino-4-chloronicotinate |
C7H7ClN2O2 |
1260666-60-1 |
|
| 5-BROMO-3-FLUORO-2-METHYLPYRIDINE |
C6H5BrFN |
1162674-74-9 |
|
| 6-CarbaMoylpyridine-3-boronic acid |
C6H7BN2O3 |
1164100-82-6 |
|
| 3-BroMo-6-ethyl-7-Methoxy-5-Methylpyrazolo[1,5-a]pyriMidine |
C10H12BrN3O |
1429309-29-4 |
|
| BMS-589154) |
C26H27N5O4 |
1686149-74-5 |
|
| 2-(Methylsulfonyl)-4-(3-pyridinyl)pyrimidine |
C10H9N3O2S |
637354-25-7 |
|
| Methyl 3-broMo-4-(difluoroMethoxy)benzoate |
C9H7BrF2O3 |
200956-56-5 |
|
| 2-(Morpholin-3-yl)ethanol hydrochloride |
C6H14ClNO2 |
1628617-14-0 |
|
| 2-(Thiophen-3-yl)Morpholine |
C8H11NOS |
1247392-06-8 |
|
| trans-4-Morpholinocyclohexanol hydrochloride |
C10H19NO2.ClH |
1588441-09-1 |
|
| (R)-2-((tert-Butoxycarbonyl)aMino)propanoic acid hydrate |
C8H17NO5 |
75638-15-2 |
|
| (R)-3-(Thiophen-3-yl)Morpholine |
C8H11NOS |
1212949-95-5 |
|
| 7-Fluoro-6-nitro-1,2,3,4-tetrahydroisoquinoline hydrochloride |
C9H10ClFN2O2 |
912846-66-3 |
|
| (R)-N,N-Diethylpyrrolidin-3-aMine dihydrochloride |
C8H19ClN2 |
1181083-20-4 |
|
| 4',4''',4'''''-(1,3,5-triazine-2,4,6-triyl)tris(([1,1'-biphenyl]-4-carboxylic acid)) |
C42H27N3O6 |
1331756-62-7 |
|
| 2-BroMo-1,3-diMethyl-4-nitrobenzene |
C8H8BrNO2 |
60956-25-4 |
|
| 2,4-difluoro-5-iodobenzoic acid |
C7H3F2IO2 |
161531-51-7 |
|
| 2-aMino-2-(4-(trifluoroMethyl)phenyl)ethanol |
C9H10F3NO |
473416-36-3 |
|
| Methyl 4-broMo-5-chlorothiophene-2-carboxylate |
C6H4BrClO2S |
1047630-72-7 |
|
| 3-(trifluoroMethyl)pyrazin-2-aMine |
C5H4F3N3 |
213019-67-1 |
|
| Ethyl 5-broMo-6-hydroxypicolinate |
C8H8BrNO3 |
1214346-74-3 |
|
| 2,2,4-Trimethyl-1,2,3,4-tetrahydroquinoline hydrochloride |
C12H18ClN |
4071-22-1 |
|
| RG2833 |
C20H25N3O2 |
1215493-56-3 |
|
| XL 228 |
C22H31N9O |
898280-07-4 |
|
| 90151-46-5 |
C8H11BrClN |
90151-46-5 |
|
| 1-(3-BroMophenyl)ethanaMine (hydrochloride) |
C8H11BrClN |
90151-46-5 |
|
| GNE 617 |
C21H15F2N3O3S |
1362154-70-8 |
|
| 1,2-Pyrrolidinedicarboxylic acid, 4-[(7-chloro-4-Methoxy-1-isoquinolinyl)oxy]-, 1-(1,1-diMethylethyl) ester, (2S,4R)- |
C20H23ClN2O6 |
1028252-15-4 |
|
| TPT-260 (Dihydrochloride), NSC55712 |
C8H14Cl2N4S3 |
2076-91-7 |
|
| P 22077 |
C12H7F2NO3S2 |
1247819-59-5 |
|
| Sorafenib IMpurity |
C8H10N2O2 |
1256817-30-7 |
|
| UNC 0631 |
C37H61N7O2 |
1320288-19-4 |
|
| UNC 0631 |
C37H61N7O2 |
1320288-19-4 |
|
| 2-hydroxy-5-(trifluoromethyl)benzaldehyde |
C8H5F3O2 |
210039-65-9 |
|
| AVE0991 |
C29H32N4O5S2 |
304462-19-9 |
|
| Methyl 3,4-diaMino-5-broMobenzoate |
C8H9BrN2O2 |
1245643-11-1 |
|
| (2S,4S)-4-FLUORO-PYRROLIDINE-2-CARBOXYLIC ACID |
C5H8FNO2 |
2438-57-5 |
|
| 4-Chloro-2-(trifluoroMethoxy)benzoic acid, 97% |
C8H4ClF3O3 |
1261605-70-2 |
|
| [(S)-Tol-Binap RuCl benzene]Cl |
C54H42Cl2P2Ru |
126085-10-7 |
|
| 2-Fluoro-N-(3,4-diMethylphenyl)benzaMide |
C15H14FNO |
136926-08-4 |
|
| 2-Methyl-6-nitro-3,4-dihydro-2H-1,4-benzoxazine |
C9H10N2O3 |
174567-34-1 |
|
| 3-(4-Methylphenyl)-5-phenyl-1,2,4-oxadiazole |
C15H12N2O |
16151-03-4 |
|
| N-(2,3-DiMethylphenyl)-3-nitrobenzaMide, 97% |
C15H14N2O3 |
102631-03-8 |
|
| N-[4-(TrifluoroMethyl)phenyl]-4-MethoxybenzaMide |
C15H12F3NO2 |
150225-43-7 |
|
| trans-1-(Boc-aMino)-4-(broMoMethyl)cyclohexane, 97% |
C12H22BrNO2 |
1222709-30-9 |
|
| (2S,5S)-2,5-DiMethylMorpholine hydrochloride |
C6H14ClNO |
1820580-79-7 |
|
| 4-BroMo-5-phenyloxazole |
C9H6BrNO |
740806-67-1 |
|
| tert-Butyl 4-(aMinoMethyl)-4-hydroxypiperidine-1-carboxylate oxalate |
C13H24N2O7 |
1588440-96-3 |
|
| 4,4'-DiaMino-2,2'-dibroMobiphenyl |
C12H10Br2N2 |
84530-60-9 |
|
| 2-(2-BroMo-1,1,2,2-tetrafluoroethoxy)-1,1,1,2,3,3-hexafluoro-3-(pentafluoroethoxy)propane |
C7BrF15O2 |
1482416-44-3 |
|
| 2,6-Bis(4,4,5,5-tetraMethyl-1,3,2-dioxaborolan-2-yl)benzo[1,2-b:4,5-b']dithiophene |
C22H28B2O4S2 |
861398-06-3 |
|
| Afatinib D6 |
C24H25ClFN5O3 |
1313874-96-2 |
|
| Cefazolin IMpurity C |
C11H12N6O4S |
56842-77-4 |
|
